THE OBESITY PARADOX IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER

被引：0
|
作者：
Martini, Alberto
Cirulli, Giuseppe
Gandaglia, Giorgio
Fossati, Nicola
Necchi, Andrea
Stabile, Armando
Cucchiara, Vito
Mazzone, Elio
Karakiewicz, Pierre I.
Sfakianos, John P.
Galsky, Matthew D.
Oh, William K.
Gallagher, Emily D.
Montorsi, Francesco
Briganti, Alberto
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD05-01
引用
收藏
页码：E55 / E55
页数：1
相关论文
共 50 条
  • [31] Monitoring of treatment for metastatic castration-resistant prostate cancer
    Hinz, Stefan
    AKTUELLE UROLOGIE, 2017, 48 (03) : 225 - 229
  • [32] Trial design for metastatic castration-resistant prostate cancer
    Sonpavde, Guru
    Fleming, Mark T.
    Hutson, Thomas E.
    Galsky, Matthew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3647 - 3648
  • [33] Drug therapies for metastatic castration-resistant prostate cancer
    El-Bahesh, Ehab
    Finianos, Antoine
    Alfaraj, Abeer
    Aragon-Ching, Jeanny B.
    FUTURE ONCOLOGY, 2015, 11 (17) : 2395 - 2403
  • [34] Re: Olaparib for Metastatic Castration-resistant Prostate Cancer
    Di Lorenzo, Giuseppe
    Autorino, Riccardo
    EUROPEAN UROLOGY, 2020, 78 (05) : 767 - 768
  • [35] Contemporary management of metastatic castration-resistant prostate cancer
    Sonpavde, Guru
    Sternberg, Cora N.
    CURRENT OPINION IN UROLOGY, 2011, 21 (03) : 241 - 247
  • [36] Olaparib for Metastatic Castration-Resistant Prostate Cancer REPLY
    de Bono, Johann
    Kang, Jinyu
    Hussain, Maha
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (09): : 891 - 891
  • [37] Targeting cMYC in metastatic castration resistant and neuroendocrine prostate cancer
    Awah, Chidiebere U.
    Ogunwobi, Olorunseun O.
    CANCER RESEARCH, 2023, 83 (07)
  • [38] Comment on: Rucaparib in castration-resistant, metastatic prostate cancer
    Brandt, Maximilian
    AKTUELLE UROLOGIE, 2024, 55 (02) : 98 - 98
  • [39] Abiraterone Acetate In Metastatic Castration-Resistant Prostate Cancer
    Yang, Lily P. H.
    DRUGS, 2011, 71 (15) : 2067 - 2077
  • [40] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Bilusic, Marijo
    Karzai, Fatima
    Cordes, Lisa M.
    Strauss, Julius
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345